Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) EPS (Basic): 2015-2025

Historic EPS (Basic) for Assembly Biosciences (ASMB) over the last 9 years, with Sep 2025 value amounting to -$0.72.

  • Assembly Biosciences' EPS (Basic) rose 52.32% to -$0.72 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.79, marking a year-over-year increase of 30.78%. This contributed to the annual value of -$6.69 for FY2024, which is 50.00% up from last year.
  • Latest data reveals that Assembly Biosciences reported EPS (Basic) of -$0.72 as of Q3 2025, which was up 45.86% from -$1.33 recorded in Q2 2025.
  • Assembly Biosciences' 5-year EPS (Basic) high stood at -$0.41 for Q3 2021, and its period low was -$4.46 during Q1 2023.
  • Its 3-year average for EPS (Basic) is -$2.12, with a median of -$1.66 in 2024.
  • As far as peak fluctuations go, Assembly Biosciences' EPS (Basic) tumbled by 361.90% in 2021, and later skyrocketed by 62.78% in 2024.
  • Over the past 4 years, Assembly Biosciences' EPS (Basic) (Quarterly) stood at -$1.37 in 2021, then reached -$1.77 in 2023, then climbed by 11.30% to -$1.57 in 2024, then surged by 52.32% to -$0.72 in 2025.
  • Its last three reported values are -$0.72 in Q3 2025, -$1.33 for Q2 2025, and -$1.17 during Q1 2025.